{
  "type": "add_node",
  "timestamp": "2025-08-14T23:25:00",
  "processed": false,
  "inputs": {
    "source_article_id": "7W5RXN0X7",
    "status": "rejected",
    "reject_category": "company",
    "reject_failure_cat": "industry_vertical"
  },
  "details": {
    "llm_topic_proposal_raw": {
      "motivation": "The significant financial results reported by Elite Pharmaceuticals, particularly the increase in revenues and operating profits driven by lisdexamfetamine products, warrant a new node to analyze the impact of pharmaceutical product performance on market dynamics.",
      "id": "elite_pharmaceuticals_lisdexamfetamine",
      "name": "Elite Pharmaceuticals Lisdexamfetamine",
      "type": "company",
      "level": "driver"
    },
    "topic_category": {
      "category": "company",
      "motivation": "It represents a company entity."
    },
    "relevance_gate": {
      "should_add": false,
      "reason": "Specific pharmaceutical product; not a macro driver or tradable asset.",
      "confidence": 0.95,
      "failure_category": "industry_vertical"
    }
  },
  "id": "none"
}